BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29496648)

  • 1. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
    Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
    Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.
    Mantripragada KC; Hamid F; Shafqat H; Olszewski AJ
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27707843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.
    Chijiiwa K; Nakano K; Ueda J; Noshiro H; Nagai E; Yamaguchi K; Tanaka M
    J Am Coll Surg; 2001 May; 192(5):600-7. PubMed ID: 11333097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.
    Toge K; Sakata J; Hirose Y; Yuza K; Ando T; Soma D; Katada T; Miura K; Takizawa K; Kobayashi T; Wakai T
    Eur J Surg Oncol; 2019 Aug; 45(8):1446-1452. PubMed ID: 30962045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal assessment of lymph node status in gallbladder cancer.
    Kim SH; Chong JU; Lim JH; Choi GH; Kang CM; Choi JS; Lee WJ; Kim KS
    Eur J Surg Oncol; 2016 Feb; 42(2):205-10. PubMed ID: 26614023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy.
    Kasumova GG; Tabatabaie O; Najarian RM; Callery MP; Ng SC; Bullock AJ; Fisher RA; Tseng JF
    Ann Surg; 2017 Oct; 266(4):625-631. PubMed ID: 28692469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.
    Foster JM; Hoshi H; Gibbs JF; Iyer R; Javle M; Chu Q; Kuvshinoff B
    Ann Surg Oncol; 2007 Feb; 14(2):833-40. PubMed ID: 17103074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic analysis of T1 and T2 stage gallbladder cancer with invasion within the gallbladder wall].
    Hou CS; Xu Z; Zhang TL; Peng Y; Ling XF; Wang LX; Zhou XS
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1620-3. PubMed ID: 17359693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection?
    Sakata J; Kobayashi T; Ohashi T; Hirose Y; Takano K; Takizawa K; Miura K; Ishikawa H; Toge K; Yuza K; Soma D; Ando T; Wakai T
    Eur J Surg Oncol; 2017 Apr; 43(4):780-787. PubMed ID: 28132788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical procedure determination based on tumor-node-metastasis staging of gallbladder cancer.
    He XD; Li JJ; Liu W; Qu Q; Hong T; Xu XQ; Li BL; Wang Y; Zhao HT
    World J Gastroenterol; 2015 Apr; 21(15):4620-6. PubMed ID: 25914471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical resection improves survival for patients with pT2 gallbladder carcinoma.
    Wise PE; Shi YY; Washington MK; Chapman WC; Wright JK; Sharp KW; Pinson CW
    Am Surg; 2001 Nov; 67(11):1041-7. PubMed ID: 11730220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder.
    Itoh H; Nishijima K; Kurosaka Y; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Saitoh Y
    Dig Dis Sci; 2005 Dec; 50(12):2231-42. PubMed ID: 16416167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
    Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant Management of Pathologic Node-Positive Disease After Definitive Surgery for Clinical T1-2 N0 Rectal Cancer.
    Polamraju P; Haque W; Verma V; Wiederhold L; Hatch S; Butler EB; Teh BS
    Clin Colorectal Cancer; 2018 Sep; 17(3):e519-e530. PubMed ID: 29753642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.
    Creasy JM; Goldman DA; Dudeja V; Lowery MA; Cercek A; Balachandran VP; Allen PJ; DeMatteo RP; Kingham TP; D'Angelica MI; Jarnagin WR
    J Am Coll Surg; 2017 May; 224(5):906-916. PubMed ID: 28216422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.